RPhotobiomodulation therapy as an adjunct therapy in burn wound care

Photobiomodulation therapy (PBMT) as an adjunct therapy for burn wound care in patients: A pilot study - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068433

Enrollment

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T212- Burn of second degree of trunk Health Condition 2: T212- Burn of second degree of trunk

Interventions

Intervention1: Photobiomodulation therapy: Patients having second degree superficial or deep dermal burns within 24 hours of injury, with TBSA involved (1-5 %). Treatment with laser- 810 nm/ 904 nm /

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having second degree superficial or deep dermal burns within 24 hours of injury, with 1.TBSA involved (1-5 %) in the upper or lower limbs, chest, abdomen and back. 2.Aged between 18 to 65 years 3. Hemodynamically stable 4. Not taking medication for any ailment

Exclusion criteria

Exclusion criteria: 1. Presence of gangrene, 2. Pregnancy 3. Photosensitivity 4. Uncontrolled systemic disease 5. Chronic skin disease 6. Diagnosed uncontrolled mental illness, alcoholism or other addictions

Design outcomes

Primary

Measure	Time frame
1.Time taken for epithelization/ appearance of granulation tissueTimepoint: 12 weeks	—

Secondary

Measure	Time frame
1. Pain : visual analog scale (VAS). 2. Biomarkers in serum: IL-1ß, IL-6, TNF-a, Precalcitonin, CRP levels. (on 1st and last visit) 3. Pain markers – Substance P /COX2 4. Quality of Scar Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Suniti Kale

VMMC and Safdarjung Hospital, New Delhi

drssarabahi@gmail.com9810054396

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026